Chair, Department of Chemical Physiology, The Scripps Research Institute; Co-director, Center for Physiological Proteomics, The Scripps Research Institute
Founder and Chairman, Sycamore Networks
Founder and CEO of Brooks Bell Inc.
This afternoon symposium will focus on recent progress in understanding the pathophysiology of aging and cognitive dysfunctions, as well as regulatory and industry perspectives on clinical drug development for older patients. Speakers include Darrell R. Abernethy of the US Food and Drug Administration. Angela Birnbaum of the University of Minnesota, and Jenny Y. Chien of Eli Lilly. A networking reception will follow. Register here.